DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

associated with these new oral agents and the importance of absolute compliance. Patients should be warned that reduced adherence or nonadherence to the treatment regimen could be fatal due to ...

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

Modified intention-to-treat (ITT) and on-treatment analyses were consistent with the overall ... and no other indication for ...

Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...

Left atrial appendage occlusion vs continuation of oral anticoagulation therapy alone is linked to reduced ischemic stroke risk in select patients with nonvalvular AF.

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...

VarmX, a biotech company developing innovative approaches for the bypass of direct oral anticoagulants targeting activated ...

The risks of thromboembolism—blood clots blocking blood flow to organs—following COVID-19 vaccination in patients with atrial ...

No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

Tom Nolan reviews this week’s research Trials of direct oral anticoagulants for atrial fibrillation have excluded patients with acute ischaemic stroke because of concerns over the risk of haemorrhagic ...

Cadrenal Therapeutics, Inc., (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and superior ...